Processa Pharmaceuticals to attend investor and industry conferences in September

HANOVER, Md., Sept. 3, 2024 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) announces that management will attend the following investor and industry conferences in September:

• HC Wainwright 26^th Annual global investment conference, September 9-11, 2024 at the Lotte New York Palace Hotel.
  Management will hold one-on-one meetings with investors and deliver a corporate presentation. The recorded presentation will be available on demand beginning Monday, September 9.^th at 7:00 a.m. Eastern Time on the Investors area the Processa website and Here.
• 2024 Congress of the European Society for Medical Oncology (ESMO), 13-17 September 2024, in Barcelona. Management will hold meetings with clinicians, researchers, key industry opinion leaders and potential partners.

About Processa Pharmaceuticals, Inc.